Busulfan in hematopoietic stem cell transplant setting

Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

(2009) JS McCune et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Population Pharmacokinetics of Oral Busulfan in Young Japanese Children Before Hematopoietic Stem Cell Transplantation

(2009) Hiroyoshi Nakamura et al.   THERAPEUTIC DRUG MONITORING

Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients

(2008) Donatella Baronciani et al.   AMERICAN JOURNAL OF HEMATOLOGY

IV Busulfan Dose Individualization in Children undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies

(2008) L. Lee Dupuis et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen

(2008) Michelle Geddes et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Once Daily i.v. Busulfan and Fludarabine (i.v. Bu-Flu) Compares Favorably with i.v. Busulfan and Cyclophosphamide (i.v. BuCy2) as Pretransplant Conditioning Therapy in AML/MDS

(2008) Borje S. Andersson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT

(2008) F K Główka et al.   BONE MARROW TRANSPLANTATION

Glutathione S-Transferase A1 Genetic Variants Reduce Busulfan Clearance in Children Undergoing Hematopoietic Cell Transplantation

(2008) L'Aurelle Johnson et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Optimal Prevention of Seizures Induced by High-Dose Busulfan

(2008) Andrea L Eberly et al.   PHARMACOTHERAPY